FDA BPA decision is a step forward, but more needs to happen, says MU expert
Tuesday, January 19, 2010 - 11:22
in Health & Medicine
The FDA shifted its stance on bisphenol A (BPA) and said that exposure to the chemical is of "some concern" for infants and children. Previously, the agency's stance was the chemical posed no risk to humans; this stance was consistent with the chemical industry's stance. Today, FDA officials declared that more research was needed and suggested reasonable steps to reduce exposure to BPA.